The Ligandable Human Proteome

Home

Proto-oncogene tyrosine-protein kinase Src

Protein kinase domain

IndexLigand NameStructurePDB codeligand desolvation
1pd3Crystal structure of c-Src in complex with pyrazolopyrimidine 33el791.13
2vspCrystal Structure of T338C c-Src covalently bound to vinylsulfonamide-pyrazolopyrimidine 93svv91.03
36g3Src kinase in complex with a sulfonamide inhibitor5j5s90.82
4pp2Structural basis for the chemical rescue of Src kinase activity3geq89.24
5pd5Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 53qlf89.2
6pd5Crystal structure of c-Src in complex with pyrazolopyrimidine 53el888.57
7bk5c-SRC kinase domain in complex with BKI RM-1-893uqf88
8vggStructure of 3MB-PP1 bound to analog-sensitive Src kinase4lgg86.72
90jnCrystal structure of 1NM-PP1 bound to analog-sensitive Src kinase4lgh86.35
10ks1Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a multitargeted kinase inhibitor3en485.49
1172fc-Src V281C bound to N-[3-({6-[(1E)-2-cyano-3-(methylamino)-3-oxoprop-1-en-1-yl]-7-(2-methoxyethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethynyl)-4-methylphenyl]-3-(trifluoromethyl)benzamide inhibitor5sys85.12
12stiCrystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.2oiq84.98
13i76c-SRC kinase domain in complex with RM-1-1764dgg84.57
1473ac-Src kinase domain in complex with Rao-IV-1515t0p84.17
15abjTargeted polypharmacology: crystal structure of the c-Src kinase domain in complex with S1, a multitargeted kinase inhibitor3en784.12
16sticrystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain complexed with imatinib3oez83.85
17sr2Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor2qq782.56
18rbsCrystal structure of Src kinase domain in complex with covalent inhibitor2hwo81.01
194a9Type II Dasatinib Analog Crystallized with c-Src Kinase4ybj81.01
20ks4Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP494, a multitargeted kinase inhibitor3en580.05
21hvyDGY-06-116, a novel and selective covalent inhibitor of SRC kinase6e6e79.36
22ihhc-Src kinase domain in complex with small molecule inhibitor3f6x78.85
234b7C-Helix-Out Dasatinib Analog Crystallized with c-Src Kinase4ybk78.2
24djkDrug resistant cSrc kinase domain in complex with covalent inhibitor PD1683933lok78.01
2511vKinase domain of cSrc in complex with a substituted pyrazolopyrimidine4o2p77.59
26p01Crystal structure of Src kinase domain in complex with Purvalanol A1yom77.52
27s03Crystal structure of Src kinase domain in complex with CGP776751yol77.23
2871dc-Src V281C kinase domain in complex with Rao-IV-1515swh75.2
29o44Crystal structure of c-SRC in complex with a covalent lysine probe5k9i74.98
30b5ac-SRC kinase domain in complex with bumpless BKI analog UW12433uqg74.86
316h3SRC kinase bound to covalent inhibitor6ate73.15
321n1Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with dasatinib3qlg72.29
33db8human Src kinase bound to kinase inhibitor bosutinib4mxo70.85
34h8hSrc kinase in complex with a quinazoline inhibitor2h8h70.69
351n1Kinase domain of cSrc in complex with Dasatinib3g5d70.13
36db8Src M314L T338M double mutant bound to kinase inhibitor bosutinib4mxz69.69
37db8Src M314L T338M double mutant bound to kinase inhibitor bosutinib4mxy69.69
38db8Human Src A403T mutant bound to kinase inhibitor bosutinib4mxx69.07
39djkCrystal structure of Src kinase domain in complex with covalent inhibitor PD1683932hwp67.66
40s56c-Src V281C kinase domain in complex with Rao-IV-1565teh66.57
4156gKinase domain of cSrc in complex with RL2355d1166.36
42gutKinase domain of cSrc in complex with compound 29B6hvf62.05
43mpzStructure of unphosphorylated c-Src in complex with an inhibitor1y5761.1
44563Kinase domain of cSrc in complex with RL2365d1060.29
45g97Kinase domain of cSrc in complex with RL405d1258.54